John Theurer Cancer Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
John Theurer Cancer Center brings 3 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2015. Its research centres on chronic myeloid leukemia, acute myeloid leukemia and lymphoma. Work covers secondary AML outcomes and ClonoSEQ-based circulating tumor DNA to predict relapse in DLBCL.
| Organization | ASH 2026 Attendance |
|---|---|
John Theurer Cancer Center Hackensack, NJ | |
Cancer center of Hackensack University Medical Center, New Jersey's largest, offering cancer diagnosis, treatment, transplant, research and survivorship care. | Booth Exhibiting at Booth 2015 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 11:00am–2:00pm Mastering Systemic Mastocytosis: Diagnostic Criteria, Risk Stratification, and Patient-Centered Treatment Across Indolent and Advanced Disease Diagnosing systemic mastocytosis, separating indolent from advanced disease, preventing anaphylaxis, and choosing between symptom control and Kit-targeted drugs. Poster Sat Dec 12 5:30pm–7:30pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at John Theurer Cancer Center
Tell us what you sell and we’ll find the people at John Theurer Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction